iShares MSCI Denmark ETF (EDEN) is an exchange-traded fund that seeks to track the investment results of the MSCI Denmark IMI 25/50 Index, a free float-adjusted market capitalization-weighted index designed to measure the performance of Danish equities. Launched on January 25, 2012, and managed by BlackRock, Inc. under its iShares brand, the ETF is domiciled in the United States with its principal operations based in New York. The fund invests at least 80% of its assets in the component securities of the underlying index or in investments with substantially similar economic characteristics, providing investors with broad exposure to large-, mid-, and small-cap Danish stocks across sectors such as health care, industrials, financials, and consumer staples; top holdings include Novo Nordisk A/S (approximately 21%), DSV A/S (around 10%), Danske Bank A/S (about 7%), Vestas Wind Systems A/S (roughly 5%), and Genmab A/S (nearly 5%), representing over 46% of the portfolio. With an expense ratio of 0.53%, assets under management of approximately $190-194 million, and semi-annual distributions—most recently declaring $1.5552 per share in December 2025—the ETF targets institutional and retail investors seeking geographic diversification focused on Denmark. Recent developments include routine portfolio rebalancing to reflect index changes and a December 2024 transaction where BlackRock acquired additional shares of the ETF, alongside ongoing dividend adjustments amid fluctuating yields around 1.7-1.9%; no major structural changes, acquisitions, or strategic shifts specific to EDEN have been reported in the last 1-2 years.